Legend: : Special Mention : Important ![]() : Very Important ![]() ![]() : Key Development |
||
| 'Rescue' therapies for the management of Helicobacter pylori infection. F Di Mario, LG Cavallaro, C Scarpignato, Dig Dis. 2006:113-30 |
||
| Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children. T Arenz, D Antos, H Russmann, M Alberer, S Buderus, M Kappler, S Koletzko, J Pediatr Gastroenterol Nutr. 2006 Aug:180-4 |
||
| Hyperemesis gravidarum and Helicobacter pylori infection: a systematic review. D Golberg, A Szilagyi, L Graves, Obstet Gynecol. 2007 Sep:695-703 |
||
| Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication. L Fuccio, ME Minardi, RM Zagari, D Grilli, N Magrini, F Bazzoli, Ann Intern Med. 2007 Oct 16:553-62 |
||
| Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. JL Tong, ZH Ran, J Shen, CX Zhang, SD Xiao, Aliment Pharmacol Ther. 2007 Jan 15:155-68 |
||
| Natural history and symptomatology of Helicobacter pylori in childhood and factors determining the epidemiology of infection. A Ozen, D Ertem, E Pehlivanoglu, J Pediatr Gastroenterol Nutr. 2006 Apr:398-404 |
||
| Review article: from gastrin to gastro-oesophageal reflux disease--a century of acid suppression. P Malfertheiner, R Fass, EM Quigley, IM Modlin, JR Malagelada, SF Moss, G Holtmann, KL Goh, P Katelaris, V Stanghellini, NJ Talley, GN Tytgat, NA Wright, Aliment Pharmacol Ther. 2006 Mar 15:683-90 |
||
| Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection. T Suzuki, K Matsuo, A Sawaki, H Ito, K Hirose, K Wakai, S Sato, T Nakamura, K Yamao, R Ueda, K Tajima, Aliment Pharmacol Ther. 2006 Jul 15:273-80 |
||
| Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. L Fuccio, RM Zagari, ME Minardi, F Bazzoli, Aliment Pharmacol Ther. 2007 Jan 15:133-41 |
||
| The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. C Wang, Y Yuan, RH Hunt, Am J Gastroenterol. 2007 Aug:1789-98 |
||
| Supplementary evidence: | ||
| Basis for the management of drug-resistant Helicobacter pylori infection. F Mégraud, Drugs. 2004:1893-904 |
||
| Diagnosis of Helicobacter pylori infection. A Makristathis, AM Hirschl, P Lehours, F Mégraud, Helicobacter. 2004:7-14 |
||
| Eradication of Helicobacter pylori for non-ulcer dyspepsia. P Moayyedi, S Soo, J Deeks, B Delaney, A Harris, M Innes, R Oakes, S Wilson, A Roalfe, C Bennett, D Forman, Cochrane Database Syst Rev. 2006:CD002096 |
||
| Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. AC Ford, BC Delaney, D Forman, P Moayyedi, Cochrane Database Syst Rev. 2006:CD003840 |
||
| H pylori antibiotic resistance: prevalence, importance, and advances in testing. F Mégraud, Gut. 2004 Sep:1374-84 |
||
| Helicobacter pylori and nonmalignant diseases. EJ Kuipers, P Malfertheiner, Helicobacter. 2004:29-34 |
||
| Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. P Malfertheiner, P Sipponen, M Naumann, P Moayyedi, F Mégraud, SD Xiao, K Sugano, O Nyrén, Lejondal H. pylori-Gastric Cancer Task Force, Am J Gastroenterol. 2005 Sep:2100-15 |
||
| Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. BC Wong, SK Lam, WM Wong, JS Chen, TT Zheng, RE Feng, KC Lai, WH Hu, ST Yuen, SY Leung, DY Fong, J Ho, CK Ching, JS Chen, China Gastric Cancer Study Group, JAMA. 2004 Jan 14:187-94 |
||
| Helicobacter pylori public health implications. P Moayyedi, RH Hunt, Helicobacter. 2004:67-72 |
||
| New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study. LG Coelho, LD Moretzsohn, WL Vieira, MA Gallo, MC Passos, JM Cindr, MC Cerqueira, L Vitiello, ML Ribeiro, S Mendonça, J Pedrazzoli-Júnior, LP Castro, Aliment Pharmacol Ther. 2005 Mar 15:783-7 |
||
| Review article: C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review. JP Gisbert, JM Pajares, Aliment Pharmacol Ther. 2004 Nov 15:1001-17 |
||
| Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing RH Hunt, F Bazzoli, Aliment Pharmacol Ther. 2004 Feb:9-16 |
||
| The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area. LY Zhou, SR Lin, SG Ding, XB Huang, L Zhang, LM Meng, RL Cui, J Zhu, Chin J Dig Dis. 2005:114-5 |
||
| Will eradication of Helicobacter pylori infection influence the risk of gastric cancer? RH Hunt, Am J Med. 2004 Sep 6:86S-91S |
||